Presentation on: Pfizer and the Pharmaceutical Industry Fletcher Leung Analyst Investment Analysis Group February 15‚ 2002 Presentation Agenda • Industry Overview: Research Based Pharmaceuticals • Pfizer – Company Specifics – Performance – Growth Drivers • Valuation – Comparables Analysis – DCF • Recommendation February 15‚ 2002 Page 2 Investment Analysis Group 1 Industry Overview Economic •Cost Effective Demographic Sociocultural •Aging Population
Premium
e s u s e f u l i n f o r m a t i o n t o t h e g e n e r a l p u b l i c ‚ c a r o w n e r s ‚ d e a l e r s a n d c a r m a n u f a c t u r i n g c o m p a n i e s i n m a n y w a y s . I A Consumer Stimul i b s t r a c t Car Industry: SWOT Analysis Dharmaraj C.‚ Sivasubramanian M. and Clement Sudhahar J. Mr. D h a r m a r a j C . ‚ A s s i s t a n t P r o f e s s o r‚ S c h o o l o f M a n a g e m e n t ‚ K a r u n y a U n i v e r s i t y ‚ C o i m b a t o r e - 6 4 1 1 1 4 ‚ Ta
Premium Automotive industry Automobile Renault
Strategic Management Major Assignment -Analysis on Teva Pharmaceutical Industries Ltd. 1. Introduction 1.1 Teva at a Glance Founded in 1901‚ Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) was formed by three young pharmacists in Jerusalem‚ Israel. Teva is a leader in the global pharmaceutical industry: one out of every seven prescriptions in the US and one out of every six prescriptions in the UK is filled with a Teva product. Ranking among the top 10 pharmaceutical companies in the world‚ it specializes
Premium Generic drug Pharmaceutical industry
|Pidilite Industries | |Parent Company |Pidilite Industries Ltd. | |Category |Consumer chemicals/ Specialty chemicals | |Sector
Premium Petroleum Brand Chemical industry
Organizational Structure in the Pharmaceuticals Industry Abstract Pfizer and Johnson & Johnson are the largest and most successful pharmaceutical companies in the world today. Each company has a massive workforce and conducts business in countries all over the globe. Both companies have used a high degree of horizontal differentiation in order to manage their business units more effectively. Operating companies are grouped together by their function‚ as well as the type of product the
Premium Management Fortune 500 Globalization
A Look at Data Mining in the Pharmaceutical Industry Topics Covered: 1) What is Data Mining and why is it used? 2) How is Data Mining used in the Pharmaceutical Industry? 3) Recent debate in the legality of Data Mining and the Pharmaceutical Industry Pharmaceutical companies are taking advantage of the growing use of technology in the healthcare arena by using data to enhance their marketing efforts and increase the quality of research and development. The process of data mining
Premium Data mining Pharmaceutical industry Pharmacology
Supply and Demand Pharmaceutical Industry In today ’s society‚ a large percentage of the population requires prescription drugs to treat injury or illness. In some cases‚ the need for drugs may be short term and in other cases‚ the drugs may be required for the remainder of an individual ’s life. In all cases‚ prescription drugs are not free; the individual or his or her insurance company pays. The type of drug and available substitutions generally drive the costs. In this paper‚ I will summarize
Premium Pharmacology Pharmaceutical industry Food and Drug Administration
for the industry going forward? 1.Though the average level of profitability in the pharmaceutical industry has been declining over time (In 2002‚ the average ROIC in the industry was 21.6%; by 2006‚ it had fallen to 14.5%)‚ historically‚ the pharmaceutical industry has been a profitable one. Because- Name of industry | Average ROIC(Between 2002 and 2006) | Pharmaceuticals | 16.45%(large) | computer hardware | 12.76% | Electronics | 3.88% | 2. The prospect for the industry for going
Premium Pharmaceutical industry Pharmacology Generic drug
| Ethics in Corporate Society | | PHARMACEUTICAL MARKETING-the growing ethical concern? Analytical Report | | | Madiha Raza Noama Naeem Sheikh Zargham Zaigham LETTER OF AUTHORIZATION November 5‚ 2011 Dear Readers‚ As students of BBA‚ our course instructor of Ethics in Corporate Society‚ Ms. Tania Danish authorized us to make a report on the “PHARMACEUTICAL MARKETING-the growing ethical concern?” We were required to make a report in accordance to our learning in the course
Premium Pharmacology Pharmaceutical industry Pharmacy
State intervention in the pharmaceutical industry: social advance or threat to innovation? By Ivan Topalovic Introduction 1/ The Product A/ European level‚ the “EMEA” B/ R.O.W. a) The Followers b) The non-Followers 2/ The Price A/ Worldwide parameters B/ Examples of price fixing per country 3/ The Place 4/ The Promotion Conclusion Appendix I Chronology in therapeutic innovation Appendix II Major pharmaceutical companies mergers / acquisitions
Premium Pharmacology Clinical trial Generic drug